Spinal Muscular Atrophy Market Is Expected to Experience a Swift Development by 2023
The Spinal Muscular Atrophy (SMA) Market is anticipated to flourish with high pace and witness stiff competition, states Transparency Market Research (TMR) in its recent research report. The major players in the market are trying to come up with easy to use and cost-effective solutions to attain an edge over their competitors. F. Hoffmann-La Roche AG, AveXis, Inc., Novartis AG, and Ionis Pharmaceuticals, Inc, and Cytokinetics, Inc. are some of the most significant players in the global spinal muscular atrophy...
View full press release